Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial

NCT00909909 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT00909909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00909909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 13, 2009
Completion date
July 31, 2027
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer